van Crugten J, Bochner F, Keal J, Somogyi A
J Pharmacol Exp Ther. 1986 Feb;236(2):481-7.
Cimetidine reduces the renal clearances of the organic cations procainamide and n-acetylprocainamide in humans and in vitro preparations by inhibition of renal cationic proximal tubular secretion. The aim of this study was to investigate in humans the selectivity of cimetidine in altering the renal handling of three different organic ions as drug substances: anion (cephalothin), cation (ranitidine) and zwitterion (cephalexin). The study was conducted in six healthy subjects who received the above drugs as single doses with and without chronic cimetidine administration. Cimetidine had no statistically significant (P greater than .05) effect on cephalothin disposition including renal clearance, but significantly reduced the renal clearance of ranitidine by over 40% between 4 and 12 hr after administration, with a concomitant increase in ranitidine plasma concentrations and elimination half-life prolongation. In addition, the renal clearance of cephalexin was reduced by cimetidine by 27% between 1 and 2 hr, but there was no change in cephalexin plasma concentrations and elimination half-life. These findings confirmed the hypothesis that cimetidine-mediated inhibition of renal drug clearance in humans is selective for a common cationic secretory transport mechanism in the proximal tubule of the kidney, rather than a nonspecific action on renal function.
西咪替丁通过抑制肾脏阳离子近端小管分泌,降低人体和体外制剂中有机阳离子普鲁卡因胺和N - 乙酰普鲁卡因胺的肾脏清除率。本研究的目的是在人体中研究西咪替丁改变三种不同有机离子作为药物的肾脏处理的选择性:阴离子(头孢噻吩)、阳离子(雷尼替丁)和两性离子(头孢氨苄)。该研究在六名健康受试者中进行,他们在接受或未接受西咪替丁长期给药的情况下,单剂量服用上述药物。西咪替丁对头孢噻吩的处置(包括肾脏清除率)没有统计学上的显著影响(P大于0.05),但在给药后4至12小时之间,显著降低了雷尼替丁的肾脏清除率超过40%,同时雷尼替丁血浆浓度升高且消除半衰期延长。此外,西咪替丁在1至2小时之间使头孢氨苄的肾脏清除率降低了27%,但头孢氨苄血浆浓度和消除半衰期没有变化。这些发现证实了以下假设:西咪替丁介导的人体肾脏药物清除抑制作用对肾脏近端小管中常见的阳离子分泌转运机制具有选择性,而非对肾功能的非特异性作用。